Publikationen (49) Publikationen von PILAR DOMINGO CALAP

2024

  1. Capsules and their traits shape phage susceptibility and plasmid conjugation efficiency

    Nature Communications, Vol. 15, Núm. 1

  2. Fighting Salmonella Infantis: bacteriophage-driven cleaning and disinfection strategies for broiler farms

    Frontiers in Microbiology, Vol. 15

  3. Prediction of Klebsiella phage-host specificity at the strain level

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Broad-range capsule-dependent lytic Sugarlandvirus against Klebsiella sp

    Microbiology spectrum, Vol. 11, Núm. 6, pp. e0429822

  2. Design and Synthesis of Copper Nanobiomaterials with Antimicrobial Properties

    ACS Bio and Med Chem Au, Vol. 3, Núm. 4, pp. 349-358

  3. Genetic determinants of host tropism in Klebsiella phages

    Cell Reports, Vol. 42, Núm. 2

  4. Inference of the Life Cycle of Environmental Phages from Genomic Signature Distances to Their Hosts

    Viruses, Vol. 15, Núm. 5

  5. Nanostructured biohybrid material with wide-ranging antiviral action

    Nano Research, Vol. 16, Núm. 8, pp. 11455-11463

  6. Natural Killers: Opportunities and Challenges for the Use of Bacteriophages in Microbial Food Safety from the One Health Perspective

    Foods, Vol. 12, Núm. 3

  7. Phages and Nanotechnology: New Insights against Multidrug-Resistant Bacteria

    BioDesign Research, Vol. 5

2022

  1. Comparative Analysis of Novel Lytic Phages for Biological Control of Phytopathogenic Xanthomonas spp

    Microbiology Spectrum, Vol. 10, Núm. 6

  2. Els virus dels bacteris: L'us de fags contra la resistència bacteriana a antibòtics

    Mètode: Revista de difusió de la investigació, Vol. 1, Núm. 112, pp. 16-22

  3. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

    Microorganisms, Vol. 10, Núm. 4

  4. Los virus de las bacterias: El uso de fagos contra la resistencia bacteriana a antibióticos

    Mètode: Revista de difusión de la Investigación, Vol. 1, Núm. 112, pp. 16-23

  5. Phenotypic and genomic comparison of klebsiella pneumoniae lytic phages: Vb_kpnm-vac66 and vb_kpnm-vac13

    Viruses, Vol. 14, Núm. 1

  6. The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. CRISPR-Cas12a-Based Detection of SARS-CoV-2 Harboring the E484K Mutation

    ACS Synthetic Biology, Vol. 10, Núm. 12, pp. 3595-3599

  2. Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniae

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 9

  3. Experimental virus evolution in cancer cell monolayers, spheroids, and tissue explants

    Virus Evolution, Vol. 7, Núm. 1

  4. Genome instability in DNA viruses

    Genome Stability: From Virus to Human Application (Elsevier), pp. 39-49